Allergen-induced CD30 expression on T cells of atopic asthmatics

Clinical and Experimental Allergy

Volumn 27, Issue 7, 1997, Pages 780-786

  Leonard, C ^a   Tormey, V ^a   Faul, J ^a   Burke, C M ^a   Poulter, L W ^b  

^a Royal College of Surgeons in Ireland   (Ireland)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Allergen; Atopic asthma; CD30; CD45RO; Lymphocyte activation

Indexed keywords

CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 2;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030797679     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1997.700840.x     Document Type: Article

References (32)

1. Sears MR. Changing patterns in asthma morbidity and mortality. J Investig Allergol Clin Immunol 1995; 5:66-72.
2. Arrighi HM. US asthma mortality: 1941-1989. Ann Allergy Asthma Immunol Apr 1995; 74:321-6.
3. Molfino NA, Slutsky AS. Near fatal asthma. Eur Resp J 1994; 7:981-990.
4. Wasserfallen JB, Schaller MD, Fiehl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Resp Dis 1990; 142:108-111.
5. Delacourt C, Labbe D, Vassault A, Brunet-Langot D, de Blic J, Scheinmann P. Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma. Allergy 1994; 49:843-7.
6. Marks GB, Tovey ER, Toelle BG et al. Mite allergen (Der p. 1) concentration in houses and its relation to the presence and severity of asthma in a population of Sydney schoolchildren. J Allergy Clin Immunol Oct 1995; 96:441-8.
7. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
8. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med 1996; 183:1-5.
9. Wierenga EA, Snoek M, De Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML. Evidence for compartmentalisation of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144:4651-6.
10. Parronchi P, De Carli M, Manetti R, Simonelli C, Piccinni MP. Aberrant IL-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects. Eur J Immunol 1992; 22:1615-20.
11. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni S. Reciprocal regulatory effects of IFN- and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148:2142-7.
12. Daher S, Santos LM, Sole D, De Lima MG, Naspitz CK, Musatti CC. Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children. J Investig Allergol Clin Immunol 1995; 5:251-4.
13. Del Prete G, De Carli M, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. Preferential expression of CD30 by human CD4+ T cells with Th2 phenotype FASEB 1995; 9:81-6.
14. Del Prete G, De Carli M, D'Elios MM et al. CD30-mediated signaling promotes the development of human T helper Type 2-like T cells. J Exp Med 1995; 182:1655-661.
15. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. IL-5 deficiency abolishes eosinophilia. airway hyperreactivity and lung damage in a mouse asthma model. J Exp Med 1995; 183:195-201.
16. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RC. Interleukin 4 but not Interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1995; 183:109-17.
17. Smith CA, Gruss H-J, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73:1349-60.
18. Falini B, Pileri S et al. CD30 (Ki-1) molecule: A new cytokine receptor of the TNF receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85:1-14.
19. Andreesen R, Osterholz, J, Lohr GW, Bross KJ. A Hodgkin cell-specific antigen is expressed on a subset of auto-and allo-activated T (helper) lymphoblasts. Blood 1984; 63:1299-1302.
20. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-58.
21. Alzona M, Jack HM, Fisher RI, Ellis TM. CD30 defines a subset of cells that produce IFN-gamma & IL-5 and exhibit enhanced B cell helper activity. J Immunol 1994; 153:2861-7.
22. Alzona M, Jack HM, Fisher RI, Ellis TM. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells. J Immunol 1995; 153:2861-7.
23. Bengtsson A, Johansson C, Linder MT, Hallden G, Van der Ploeg I, Scheynius A. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J Leukocyte Biol 1995; 58:683-9.
24. Hamann D, Hilkens CMU, Grogan JL, Lens SMA. Kapsenberg ML, Yazdanbakhsh M, Van Lier RAW. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996; 156:1387-91.
25. Del Prete G, DeCarli M, Almerigogna F, Daniel CK, D'Elios HM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. CD30, TH2 cytokines and HIV infection: a complex and fascinating link. Immunology Today 1995; 16:76-80.
26. Manetti R, Annunziato F, Biagiotti R, Giudizi MG, Piccinni MP, Giannarini L, Sumpognaro S, Parronchi P, Vinanle F, Pizzolo G. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 1994; 180:2407-11.
27. Maggi E, Annunziato F, Manetti R, Biagiotti R, Giudizi MG, Ravina A, Almerigogna F, Boiani N, Alderson M, Romagnani S. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Immunity 1995; 3:251-5.
28. Caligaris-Cappio F, Betero MT, Converso M, Stacchini A, Vinante F, Romagnani S, Pizzolo G. Circulating levels of soluble CD30, a marker of cells producing Th2- type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1993; 13:339-43.
29. Vinante F, Morosato L, Siviero F, Nadali G, Rigo A, Veneri D, de Sabata D, Vincenzi C, Chilosi M, Semenzato G et al. Soluble forms of p. 55-IL-2R alpha, CD8 and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis. Haematologica 1994; 7:413-9.
30. Chavance M, Perrot JY, Annesi I. Smoking, CD45RO (Memory) and CD45RA (Naive) CD4+ T cells. Am Rev Resp Dis 1993; 148:237-40.
31. Nasert S, Burtchen N, Kussebi F, Millner M, Kroczek R, Jung T, Schwinzer R, Wahn U, Renz H. Stimulation of IgE and IgA production by CD45RA T helper cells in atopic patients. J Immunol 1996; 157:441-8.
32. Djukanovic R, Feather I, Gratziou C, Walls A, Peroni D, Bradding P, Judd M, Howarth PH, Holgate ST. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax 1996; 51:575-81.